Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U6 small nuclear 15, pseudogene (RNU6-15P)** is a pseudogene belonging to the U6 family of small nuclear RNAs (snRNAs). U6 snRNAs are critical components of the major spliceosome complex, participating in pre-mRNA splicing as catalytic RNA elements, but pseudogene variants like RNU6-15P are considered non-functional and do not produce a functional RNA product. The U6 snRNAs as a group are highly conserved, non-coding RNAs transcribed by RNA polymerase III and involved in essential nuclear processes, but RNU6-15P itself does not contribute to RNA splicing or gene regulation due to its pseudogene status[3].\n\n**Explanation and context:**\n- RNU6-15P is annotated as a **pseudogene**, meaning it is a genomic sequence similar to the functional RNA, U6 snRNA, but it does not produce an active RNA molecule and lacks biological function[3].\n- Functional U6 snRNAs are integral to the spliceosome and RNA splicing; however, pseudogenes like RNU6-15P are **not targets for drugs, not involved in disease, do not have molecular mechanisms of action, and are not used as biomarkers or therapeutic targets**[1][3].\n- Pseudogenes may serve as transcriptional noise or have subtle regulatory roles in rare cases, but there is no recognized biological function for RNU6-15P specifically[3].\n\n**Special notes:** \n- The name and gene symbol (RNU6-15P) indicate it is a pseudogene (“P” suffix) and not a true, functional snRNA.\n- The conjecture that it might be a target is incorrect; there is no evidence it is targeted therapeutically, connected to any pathways of pathological or pharmacological interest, or used as a research or diagnostic marker.\n- Some confusion may arise because functional U6 snRNAs (non-pseudogene forms) are used as normalization controls in molecular biology studies, but pseudogenes like RNU6-15P are not[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 15, pseudogene (RNU6-15P).